Search General Info
Search Education
Search Partnering Companies

Zavain Dar

New York, New York, United States
Zavain invests at the intersection and union of cutting-edge biotech and software. Zavain has led Lux’s investments in Primer, a machine intelligence startup; Clarifai, which democratizes cutting edge deep neural networks; Auransa, which is developing novel medicines based on computational insight applied to genomic data; Recursion which uses automation and deep learning to develop drugs for rare diseases; Tempo Automation, which applies software and automation to electronics manufacturing; Rigetti Computing, which is fabricating some of the fastest quantum chips in the world; Braid, which is bringing AI to medical diagnostics; Visor, which aims to simplify tax preparation; Computable Labs, which is building a decentralized data marketplace; Cryptonumerics, a data control company acquired by Snowflake Computing; The Stacks Foundation, which is making Bitcoin programmable; Runway, which is putting machine learning tools into the hands of creators; LabGenius, a protein drug discovery company; Anagenex, a drug discovery company leveraging DNA encoded libraries, Hugging Face, an open-source company democratizing Natural Language Processing; and Thrive Earlier Detection, an early cancer detection company that Exact Sciences agreed to acquire for $2.15 billion in 2020.

Previously Zavain was an investor at Eric Schmidt’s Innovation Endeavors. There he sourced and led the firm’s investments in early stage technology companies including Zymergen and BlockStream. Zavain drafted the firm’s theses in Genetics, Synthetic Biology, and the Blockchain.

Prior to VC, Zavain was a founder and computer scientist. At Discovery Engine (acquired by Twitter), he engineered machine learning and AI systems across a proprietary distributed computing framework to build web scale-ranking algorithms. Zavain was also a cofounder of Fountainhop, one of the first hyper-local social networks.

Zavain holds a BS in symbolic systems and an MS in computer science from Stanford where he was a researcher in Stanford’s AI Lab. He is currently a Lecturer at Stanford and has taught quarter long seminars in Cryptocurrencies, Artificial Intelligence and Philosophy, and Venture Capital.
Speaking In
12:45 PM - 1:30 PM (EDT)
Monday, June 14

Machine learning has the potential to help scientists transform several elements of disease…